Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_assertion type Assertion NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_head.
- NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_assertion description "[We have examined the association of these single nucleotide polymorphisms, together with others tagging the HMMR gene, in a larger, European case-control study and find no association of any of them with risk of breast cancer: rs10515860 [odds ratio (OR; AA/GG), 0.85; 95% confidence interval (CI), 0.65-1.12; P(trend) = 0.9], rs299290 [OR (CC/TT), 1.00; 95% CI, 0.87-1.15; P(trend) = 0.7], rs3756648 (rs7712023) [OR (TT/CC), 0.93; 95% CI, 0.84-1.02; P(trend) = 0.1], rs299284 [OR (TT/CC), 1.01; 95% CI, 0.76-1.35; P(trend) = 0.5], and rs13183712 [OR (TT/GG), 1.04; 95% CI, 0.88-1.23; P(trend) = 0.6].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_provenance.
- NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_assertion evidence source_evidence_literature NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_provenance.
- NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_assertion SIO_000772 19064580 NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_provenance.
- NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_assertion wasDerivedFrom befree-20140225 NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_provenance.
- NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_assertion wasGeneratedBy ECO_0000203 NP778412.RAjvVFtSzTLrjo_BOs6RPKU2x_VAZoV1aq-tSPBJorKKQ130_provenance.